D
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -281.20K -189.50K 3.21M -283.00K -377.10K
Total Depreciation and Amortization 511.00K 410.40K 339.30K 259.50K 252.90K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 526.90K 463.70K -3.00M 345.30K 567.10K
Change in Net Operating Assets 318.00K -334.80K -230.70K -385.70K -521.10K
Cash from Operations 1.07M 349.80K 322.90K -63.80K -78.20K
Capital Expenditure -318.00K -283.60K 764.40K -876.90K -678.90K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -800.10K -22.00K -1.54M
Divestitures -- -- -- -- --
Other Investing Activities -393.90K -281.20K -1.49M -122.40K -148.40K
Cash from Investing -711.90K -564.70K -1.53M -1.02M -2.37M
Total Debt Issued 5.63M 3.76M 6.24M 1.76M 438.00K
Total Debt Repaid -745.00K -641.50K -3.89M -957.00K -1.17M
Issuance of Common Stock -- -- 0.00 960.00K 5.29M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -593.00K -478.00K -530.00K -403.00K -889.00K
Cash from Financing 3.10M 1.84M 1.30M 993.50K 2.68M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 3.46M 1.63M 94.30K -91.60K 235.30K